Helbig, Doris, Ziemer, Mirjana, Dippel, Edgar, Erdmann, Michael, Hillen, Uwe, Leiter, Ulrike, Mentzel, Thomas, Osterhoff, Georg, Ugurel, Selma, Utikal, Jochen, von Bubnoff, Dagmar, Weishaupt, Carsten and Grabbe, Stephan (2022). S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS). J. Dtsch. Dermatol. Ges., 20 (2). S. 235 - 244. HOBOKEN: WILEY. ISSN 1610-0387

Full text not available from this repository.

Abstract

Atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) are rare cutaneous neoplasms representing histomorphological, genetic as well as epigenetic variants of a disease spectrum. Both tumors typically manifest as nonspecific, often ulcerated, skin- to flesh-colored nodules in chronically sun-damaged skin of elderly male patients. AFX is a rather well demarcated, often rapidly growing tumor. PDS tumors are poorly circumscribed and are characterized by aggressive infiltrative growth. Fast as well as slow growth behavior has been reported for both tumors. Histologically, both are composed of spindle-shaped and epithelioid tumor cells with pleomorphic nuclei as well as atypical multinucleated giant cells. Atypical mitoses are common. In contrast to AFX, PDS involves relevant parts of the subcutis and shows areas of tumor necrosis and/or perineural infiltration. Due to the poorly differentiated nature of AFX/ PDS (Grade 3), histopathologically similar cutaneous sarcomas, undifferentiated carcinomas, melanomas and other diseases have to be excluded by immunohistochemical analysis. The treatment of choice is micrographically controlled surgery. In cases of AFX, a cure can be assumed after complete excision. Local recurrence rates are low as long as PDS tumors are surgically removed with a safety margin of 2 cm. Metastasis is rare and mostly associated with very thick or incompletely excised tumors; it mainly affects the skin and lymph nodes. Distant metastasis is even more rare. No approved and effective systemic therapy has been established.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Helbig, DorisUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ziemer, MirjanaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dippel, EdgarUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Erdmann, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hillen, UweUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Leiter, UlrikeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mentzel, ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Osterhoff, GeorgUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ugurel, SelmaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Utikal, JochenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
von Bubnoff, DagmarUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Weishaupt, CarstenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Grabbe, StephanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-694410
DOI: 10.1111/ddg.14700
Journal or Publication Title: J. Dtsch. Dermatol. Ges.
Volume: 20
Number: 2
Page Range: S. 235 - 244
Date: 2022
Publisher: WILEY
Place of Publication: HOBOKEN
ISSN: 1610-0387
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
MALIGNANT FIBROUS HISTIOCYTOMA; CD99 IMMUNOREACTIVITY; CD10; MUTATIONS; EXPRESSION; FEATURES; FREQUENT; SERIES; SKIN; P63Multiple languages
DermatologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/69441

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item